| Study |
Reference |
|
Al Khalaf - Calcium channel blockers (Controls unexposed, disease free), 2022
|
Al Khalaf Role of Antihypertensive Treatment and Blood Pressure Control in the Occurrence of Adverse Pregnancy Outcomes: a Population-Based Study of Linked Electronic Health Records. Hypertension 2022; 79:1548-1558
|
|
Al Khalaf - Calcium channel blockers (Controls unexposed, sick), 2022
|
Al Khalaf Role of Antihypertensive Treatment and Blood Pressure Control in the Occurrence of Adverse Pregnancy Outcomes: a Population-Based Study of Linked Electronic Health Records. Hypertension 2022; 79:1548-1558
|
|
Bateman - Calcium blockers, 2015
|
Bateman Calcium Channel Blocker Exposure in Late Pregnancy and the Risk of Neonatal Seizures. Obstet Gynecol 2015; 126:271-278
|
|
Bayliss - Calcium blockers, 2002
|
Bayliss Anti-hypertensive drugs in pregnancy and fetal growth: evidence for 'pharmacological programming' in the first trimester? Hypertens Pregnancy 2002; 21:161-74
|
|
Caton - Calcium blockers, 2009
|
Caton Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension 2009; 54:63-70
|
|
Darcie - Isradipine, 2004
|
Darcie Glycemia in newborns of hypertensive mothers
according to maternal treatment. Rev. Hosp Clin. 2004, 59, 244–250
|
|
Fisher - Calcium blockers (Controls unexposed, disease free), 2017
|
Fisher Maternal Antihypertensive Medication Use and Congenital Heart Defects: Updated Results From the National Birth Defects Prevention Study. Hypertension 2017; 69:798-805
|
|
Fisher - Calcium blockers (Controls unexposed, sick), 2017
|
Fisher Maternal Antihypertensive Medication Use and Congenital Heart Defects: Updated Results From the National Birth Defects Prevention Study. Hypertension 2017; 69:798-805
|
|
Fisher a - Calcium blockers, 2018
|
Fisher Maternal antihypertensive medication use and selected birth defects in the National Birth Defects Prevention Study. Birth Defects Res 2018; 110:1433-1442
|
|
Fisher b - Calcium inhibitors (Controls unexposed, disease free), 2018
|
Fisher Maternal Hypertension, Antihypertensive Medication Use, and Small for Gestational Age Births in the National Birth Defects Prevention Study, 1997-2011. Matern Child Health J 2018; 22:237-246
|
|
Fisher b - Calcium inhibitors (Controls unexposed, sick), 2018
|
Fisher Maternal Hypertension, Antihypertensive Medication Use, and Small for Gestational Age Births in the National Birth Defects Prevention Study, 1997-2011. Matern Child Health J 2018; 22:237-246
|
|
Fitton - Calcium Blockers, 2021
|
Fitton Congenital defects and early childhood outcomes following in-utero exposure to antihypertensive medication. J Hypertens 2021; 39:581-588
|
|
Fitton - Calcium blockers (Controls unexposed, disease free), 2020
|
Fitton In Utero Antihypertensive Medication Exposure and Neonatal Outcomes: A Data Linkage Cohort Study. Hypertension 2020; 75:628-633
|
|
Fitton - Calcium blockers (Controls unexposed, sick), 2020
|
Fitton In Utero Antihypertensive Medication Exposure and Neonatal Outcomes: A Data Linkage Cohort Study. Hypertension 2020; 75:628-633
|
|
Ishikawa - Amlodipine (Controls unexposed, disease free), 2023
|
Ishikawa Risk of major congenital malformations associated with first-trimester antihypertensives, including amlodipine and methyldopa: A large claims database study 2010-2019. Pregnancy Hypertens 2023; 31:73-83
|
|
Ishikawa - Amlodipine (Controls unexposed, sick), 2023
|
Ishikawa Risk of major congenital malformations associated with first-trimester antihypertensives, including amlodipine and methyldopa: A large claims database study 2010-2019. Pregnancy Hypertens 2023; 31:73-83
|
|
Lennestal - Calcium inhibitors, 2009
|
Lennestal Maternal use of antihypertensive drugs in early pregnancy and delivery outcome, notably the presence of congenital heart defects in the infants. Eur J Clin Pharmacol 2009; 65:615-25
|
|
Magee - Calcium blockers, 1996
|
Magee LA The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study. Am J Obstet Gynecol 1996;174:823-8
|
|
Mito - Amlodipine, 2019
|
Mito Safety of Amlodipine in Early Pregnancy. J Am Heart Assoc 2019; 8:e012093
|
|
Nakhai-Pour - Calcium blockers, 2010
|
Nakhai-Pour Antihypertensive medication use during pregnancy and the risk of major congenital malformations or small-for-gestational-age newborns. Birth Defects Res B Dev Reprod Toxicol 2010; 89:147-54
|
|
Sorensen - Calcium blockers, 2001
|
Medveczky The use of drugs in mothers of offspring with neural-tube defects. Pharmacoepidemiol Drug Saf 2004; 13:443-55 Sorensen The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers. Acta Obstet Gynecol Scand 2001; 80:397-401
|
|
Su - Calcium blockers (Controls unexposed, disease free), 2013
|
Su Pregnancy outcomes of anti-hypertensives for women with chronic hypertension: a population-based study. PLoS One 2013; 8:e53844
|
|
Su - Calcium blockers (Controls unexposed, sick), 2013
|
Su Pregnancy outcomes of anti-hypertensives for women with chronic hypertension: a population-based study. PLoS One 2013; 8:e53844
|
|
Vaclavik - Amlodipine, 2024
|
Vaclavik, J. MATERNAL AND FETAL OUTCOMES OF VARIOUS ANTIHYPERTENSIVE TREATMENT REGIMENS DURING PREGNANCY: INSIGHTS FROM THE CZECH NATIONAL REGISTRY 2012-2022 Int. J. Hypertens. 2024; 42:e10-.
|
|
Van Gelder - Calcium blockers, 2015
|
van Gelder MM Maternal hypertensive disorders, antihypertensive medication use, and the risk of birth defects: a case-control study. BJOG 2015;122:1002-9
|
|
Van Zutphen - Calcium blockers, 2014
|
Caton Maternal hypertension, antihypertensive medication use, and the risk of severe hypospadias. Birth Defects Res A Clin Mol Teratol 2008; 82:34-40 Van Zutphen AR Maternal hypertension, medication use, and hypospadias in the National Birth Defects Prevention Study. Obstet Gynecol 2014;123:309-17
|
|
Vasilakis-Scaramozza - Calcium blockers, 2013
|
Vasilakis-Scaramozza Antihypertensive drugs and the risk of congenital anomalies. Pharmacotherapy 2013; 33:476-82
|
|
Weber-Schoendorfer - Calcium blockers, 2008
|
Weber-Schoendorfer C The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study. Reprod Toxicol 2008;26:24-30
|
|
Wide-Swensson - Isradipine, 1995
|
Wide-Swensson Calcium channel blockade (isradipine) in treatment of hypertension in pregnancy: a randomized placebo-controlled study. Am J Obstet Gynecol 1995; 173:872-8
|
|
Zarante - Nifedipine, 2009
|
Zarante Impact and risk factors of craniofacial malformations in a Colombian population. Int. J. Pediatr. Otorhinolaryngol. 2009; 73:1434-7
|
